Germline Variants as Risk Factors for Early-Onset Lung Adenocarcinoma
Journal of Thoracic Oncology · 2025-11 · 20 (11) · 1573-1576
DOI: 10.1016/j.jtho.2025.08.012 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Thoracic Oncology, 2025-11. Verfasst von Alena Yermalovich und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, M…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Departments of Genetics and Medicine, Harvard Medical Sc…
Zitieren
APA
Yermalovich, A., & Meyerson, M. (2025). Germline Variants as Risk Factors for Early-Onset Lung Adenocarcinoma. Journal of Thoracic Oncology, 20(11), 1573-1576. https://doi.org/10.1016/j.jtho.2025.08.012
Vancouver
Yermalovich A, Meyerson M. Germline Variants as Risk Factors for Early-Onset Lung Adenocarcinoma. Journal of Thoracic Oncology. 2025;20(11):1573-1576. doi:10.1016/j.jtho.2025.08.012
BibTeX
@article{Yermalovich2025,
author = {Yermalovich, Alena and Meyerson, Matthew},
title = {Germline Variants as Risk Factors for Early-Onset Lung Adenocarcinoma},
journal = {Journal of Thoracic Oncology},
year = {2025},
volume = {20},
number = {11},
pages = {1573--1576},
doi = {10.1016/j.jtho.2025.08.012}
}
EUVIMED